{"page":{"totalFilteredElements":347},"studies":[{"active":true,"description":"Prospective study with continuous and fixed-Duration Ibrutinib based First Line Treatment in patients with Chronic Lymphocytic Leukemnia in real world setting","eudractNumber":null,"id":9253,"indications":[{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym3","name":"Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2023-03-03T13:01:22+01:00","shortTitle":"Reality 2","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Simultan integrierter Boost in der HNO Quality Control Registry","eudractNumber":null,"id":2554,"indications":[{"id":"hno","name":"Kopf/Hals Tumoren"},{"id":"hno3","name":"Kopf-Hals-Malignome"}],"mutations":[],"nctNumber":"NCT06831903","phase":{"id":"ph_13","name":"Therapieoptimierung"},"recruitmentStart":"2019-10-01T13:37:34+02:00","shortTitle":"Register SIB HNO","therapeutical":false,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Patientenregister Seltene Histiocytosen","eudractNumber":null,"id":10623,"indications":[{"id":"ped","name":"Kindliche Tumoren (inkl. Gehirntumoren und Leukämien)"},{"id":"ped4","name":"Weitere solide Tumore"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2016-01-01T10:45:51+01:00","shortTitle":"Register für Seltene Histiocytosen","therapeutical":true,"therapyLines":[{"id":"tl_1","name":"Erstlinie"}]},{"active":true,"description":"Register und Biobank\nseltene maligne Tumoren der Schilddr&#252;se und Nebenschilddr&#252;sen","eudractNumber":null,"id":1811,"indications":[{"id":"sch","name":"Schilddrüsenkarzinom"},{"id":"nen","name":"Bösartige Tumoren der Nebenniere"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2013-10-04T09:56:39+02:00","shortTitle":"Register und Biobank für seltene maligne Tumoren der Schilddrüse und Nebenschilddrüsen","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"Mammakarzinom des Mannes - Eine prospektive Registerstudie der Universit&#228;tsfrauenklinik Magdeburg in Zusammenarbeit mit der GBG (German Breast Group) zur Diagnostik und Therapie des Mammakarzinoms des Mannes<div><br /></div><div>DRKS00009536</div>","eudractNumber":null,"id":1491,"indications":[{"id":"bru","name":"Brustkrebs (Mammakarzinom)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2009-04-01T14:01:18+02:00","shortTitle":"Registerstudie Mammakarzinom des Mannes","therapeutical":false,"therapyLines":[]},{"active":true,"description":"<div><div><div>Male breast cancer - A prospective registry study of the University Women's Hospital Magdeburg in cooperation with the GBG (German Breast Group) on the diagnosis and treatment of male breast cancer</div><div><br /></div><div>DRKS00009536</div></div><div><br /></div></div>","eudractNumber":null,"id":6191,"indications":[{"id":"bru","name":"Brustkrebs (Mammakarzinom)"}],"mutations":[],"nctNumber":null,"phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2009-09-08T13:56:24+02:00","shortTitle":"Registerstudie Mammakarzinom des Mannes","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Tumor-Treating-Fields (Optune&#8482;) in der Routineanwendung bei der\nPrim&#228;rtherapie des Glioblastoms: multizentrische Registerstudie zur Erfassung\nder Therapieeffektivit&#228;t und des Rezidivmusters&#8220;","eudractNumber":null,"id":6513,"indications":[{"id":"zns","name":"Hirntumore (ZNS Tumore)"},{"id":"zns1","name":"Astrozytäre Gliome (Astrozytom, Glioblastom)"},{"id":"zns2","name":"Meningeom"},{"id":"zns3","name":"Akustikusneurinom (Vestibularis-Schwannom)"}],"mutations":[],"nctNumber":null,"phase":null,"recruitmentStart":"2020-11-23T11:11:19+01:00","shortTitle":"Registerstudie Optune","therapeutical":true,"therapyLines":[{"id":"tl_5","name":"N/A"}]},{"active":true,"description":"PROVIDENCE&#160;- Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive or HER2-low Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan (PROVIDENCE)","eudractNumber":null,"id":10995,"indications":[{"id":"bru","name":"Brustkrebs (Mammakarzinom)"}],"mutations":[],"nctNumber":"NCT05573893","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2022-09-18T09:19:32+02:00","shortTitle":"Registerstudie PROVIDENCE","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Retentionsrate von Acalabrutinib in einem nicht-interventionellen Setting","eudractNumber":null,"id":10601,"indications":[{"id":"lym","name":"Lymphome inkl. Morbus Hodgkin, Multiples Myelom und Chronisch Lymphatischer Leukämie (CLL)"},{"id":"lym3","name":"Non-Hodgkin Lymphome (inkl. Chron. Lymphat. Leukämie, CLL)"}],"mutations":[],"nctNumber":"NCT05645172","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2023-01-05T09:26:40+01:00","shortTitle":"Retain","therapeutical":false,"therapyLines":[]},{"active":true,"description":"Clinical Research Platform For Molecular Testing, Treatment, Quality Of Life And Outcome Of Patients With Esophageal, Gastric Or Gastroesophageal Junction Cancer Requiring Palliative Systemic Therapy (SAPHIR)","eudractNumber":null,"id":8285,"indications":[{"id":"gio","name":"Bösartige Erkrankungen des oberen Verdauungstraktes (Oesophagus, Magen, gastrooesophagealer Übergang)"},{"id":"gio1","name":"Karzinom der Speiseröhre (Oesophaguskarzinom, inkl. gastrooesophagealer Übergang)"},{"id":"gio2","name":"Karzinom des gastrooesophagealen Übergangs"},{"id":"gio3","name":"Magenkarzinom"}],"mutations":[],"nctNumber":"NCT04290806","phase":{"id":"ph_2","name":"Anwendungsbeobachtung"},"recruitmentStart":"2019-12-19T13:29:37+01:00","shortTitle":"SAPHIR","therapeutical":false,"therapyLines":[]}]}